Veranova provides an extensive portfolio of generic APIs. Our products cover a wide range of therapeutic classes, such as anti-cancer, anti-addiction, psychiatric disorders, and pain management.

Our API offering is supported by our network of GMP-compliant commercial manufacturing facilities in Europe and North America, to meet your global product requirements.

Download API and Controlled Substance Product Guide
 

API products

Filter by:

Apomorphine HCl

CAS number: 41372-20-7
See more

Atropine Sulfate

CAS number: 5908-99-6
See more

Auranofin

CAS number: 34031-32-8
See more

Carboplatin

CAS number: 41575-94-4
See more

Carmustine

CAS number: 154-93-8
See more

Cisplatin

CAS number: 15663-27-1
See more

Decitabine

CAS number: 2353-33-5
See more

Dofetilide

CAS number: 115256-11-6
See more

Edrophonium Chloride

CAS number: 116-38-1
See more

Isoproterenol HCl

CAS number: 51-30-9
See more

Lurasidone HCl

CAS number: 367514-88-3
See more

Miglustat

CAS number: 72599-27-0
See more

Naloxone HCl

CAS number: 51481-60-8
See more

Nintedanib

CAS number: 656247-18-6
See more

Pirfenidone

CAS number: 53179-13-8
See more

Controlled substances

Learn more

Featured insights from our experts

Read more

Bioorthogonal Chemistry

We were honored to welcome Nobel Prize laureate, Professor of Chemistry at Stanford University, and Veranova Advisory Board member, Carolyn Bertozzi to our SCALE 2025 Symposium event in July.

Listen to Carolyn’s talk where she discusses her decades-long work developing bioorthogonal and click chemistries, and how these innovations are enabling the construction of complex therapeutic modalities across pharma today.

Analytical Techniques for Antibody-Drug Conjugates (ADCs)

Read our latest white paper highlighting critical analytical techniques necessary for the characterization of ADCs, emphasizing their physicochemical properties, biological activity, stability assessments, and regulatory implications.

From Magic to Medicine: Synthesis of Psilocybin for Therapeutics

In recent years, interest in psychedelics for therapeutic use has increased. Among these is psilocybin, the world’s most studied psychedelic compound for the treatment of mental health conditions. This Expert Insight explores the potential of this molecule, and the challenges associated with synthesizing it at scale.

Veranova is your next great decision

Discover new ways to advance your science with Veranova.

Contact us